KHC
NSPR icon

Koesten Hirschmann & Crabtree’s InspireMD NSPR Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$5 – 166
2025
Q3 		$5 Buy
+2
New +$5 ﹤0.01% 261

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Koesten Hirschmann & Crabtree's NSPR Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of InspireMD (NSPR) in Q4 2025, closing a stake of 2 shares — an estimated $5 sold.

Koesten Hirschmann & Crabtree first reported a position in NSPR in Q3 2025 and held it in 1 quarter. The position peaked at $5 in Q3 2025. 45 funds tracked by Wall St. Rank hold NSPR as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining InspireMD position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 2 InspireMD shares in Q4 2025, an estimated $5.
  • Koesten Hirschmann & Crabtree first reported a position in InspireMD in Q3 2025 and held it in 1 quarter.
  • Koesten Hirschmann & Crabtree's InspireMD position peaked at $5 in Q3 2025.
  • 45 funds tracked by Wall St. Rank held InspireMD as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.